ENRIGHT PATRICK G

CIK 00012538864 companiesBURLINGAME, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001253886

Recent Transactions

25 trades

Award
CORCEPT THERAPEUTICS INC$CORT
Stock Options (right to buy)
2013-05-17+30,000→ 30,000 total
Award
CORCEPT THERAPEUTICS INC$CORT
Stock Options (right to buy)
2013-05-17+30,000→ 30,000 total
Exercise of In-Money
CORCEPT THERAPEUTICS INC$CORT
Common Stock
2012-03-29$2.96/sh+856,644→ 13,433,573 total
Exercise of In-Money
CORCEPT THERAPEUTICS INC$CORT
Warrants (Right to Buy)
2012-03-29$0.13/sh−856,644→ 0 total
Purchase
CORCEPT THERAPEUTICS INC$CORT
Warrants (Right to Buy)
2012-03-29$0.13/sh+856,644→ 856,644 total
Exercise of In-Money
CORCEPT THERAPEUTICS INC$CORT
Common Stock
2012-03-29$2.96/sh+856,644→ 13,433,573 total
Purchase
CORCEPT THERAPEUTICS INC$CORT
Warrants (Right to Buy)
2012-03-29$0.13/sh+856,644→ 856,644 total
Exercise of In-Money
CORCEPT THERAPEUTICS INC$CORT
Warrants (Right to Buy)
2012-03-29$0.13/sh−856,644→ 0 total
Purchase
CORCEPT THERAPEUTICS INC$CORT
Common Stock
2011-01-21$3.90/sh+750,000→ 12,576,929 total
Award
CORCEPT THERAPEUTICS INC$CORT
Stock Option (Right to Buy)
2008-06-10+70,000→ 70,000 total
Award
CORCEPT THERAPEUTICS INC$CORT
Stock Option (Right to Buy)
2008-06-10+70,000→ 70,000 total
Award
SEQUENOM INC
Stock Option (Right-to-buy)
2007-06-22+20,000→ 20,000 total
Award
SEQUENOM INC
Stock Option (Right-to-buy)
2007-06-22+20,000→ 20,000 total
Award
SEQUENOM INC
Stock Option (Right-to-buy)
2007-06-22+20,000→ 20,000 total
Conversion
Molecular Templates, Inc.
Series B Preferred Stock
2005-02-09−3,312,006→ 0 total
Conversion
Molecular Templates, Inc.
Series B Preferred Stock
2005-02-09−3,312,006→ 0 total
Conversion
Molecular Templates, Inc.
Common Stock
2005-02-09+3,312,006→ 3,553,725 total
Purchase
Molecular Templates, Inc.
Common Stock
2005-02-09$7.00/sh+241,719→ 0 total
Conversion
Molecular Templates, Inc.
Series B Preferred Stock
2005-02-09−3,312,006→ 0 total
Conversion
Molecular Templates, Inc.
Common Stock
2005-02-09+3,312,006→ 3,553,725 total
Purchase
Molecular Templates, Inc.
Common Stock
2005-02-09$7.00/sh+241,719→ 0 total
Purchase
Molecular Templates, Inc.
Common Stock
2005-02-09$7.00/sh+241,719→ 0 total
Conversion
Molecular Templates, Inc.
Common Stock
2005-02-09+3,312,006→ 3,553,725 total
Award
Vaneltix Pharma, Inc.
Non-Qualified Stock Option (right to buy)
2004-12-03+10,000→ 10,000 total
Award
Vaneltix Pharma, Inc.
Non-Qualified Stock Option (right to buy)
2004-12-03+10,000→ 10,000 total

Companies

Recent Filings

Address

863A MITTEN ROAD

BURLINGAME, CA, 94010

View on SEC.gov